This is a multi-disciplinary group focused on the use of pulsed low dose radiation to reduce the toxicity of radiation and enhance therapeutic efficacy. In addition, biomarkers of toxicity and response are being evaluated in preclinical in vivo models and efforts are ongoing to develop clinical trials.
Members include Yanqun Dong, Niklas Finnberg, Charlie Ma, Mark Hallman, Joshua Meyer, Lanlan Zhou.